ABVC BioPharma Achieves First Operational Profit and Secures Licensing Agreements for Potential $292 Million Income
November 14, 2024 — ABVC BioPharma achieved its first operational profit, secured global licensing agreements, and demonstrated strong financial performance, positioning the company for sustained growth and increased shareholder value.